Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4204256
Max Phase: Preclinical
Molecular Formula: C23H15F8N3OS
Molecular Weight: 533.44
Molecule Type: Small molecule
Associated Items:
ID: ALA4204256
Max Phase: Preclinical
Molecular Formula: C23H15F8N3OS
Molecular Weight: 533.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1cc(F)ccc1F)[C@H](NC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1
Standard InChI: InChI=1S/C23H15F8N3OS/c24-15-6-7-17(25)18(11-15)33-20(35)19(12-4-2-1-3-5-12)34-21(36)32-16-9-13(22(26,27)28)8-14(10-16)23(29,30)31/h1-11,19H,(H,33,35)(H2,32,34,36)/t19-/m1/s1
Standard InChI Key: MLUCBNZUVZVZSJ-LJQANCHMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 533.44 | Molecular Weight (Monoisotopic): 533.0808 | AlogP: 6.67 | #Rotatable Bonds: 5 |
Polar Surface Area: 53.16 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.11 | CX Basic pKa: | CX LogP: 6.88 | CX LogD: 6.88 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.25 | Np Likeness Score: -1.66 |
1. Ouyang L, Zhang L, Zhang S, Yao D, Zhao Y, Wang G, Fu L, Lei P, Liu B.. (2018) Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment., 61 (7): [PMID:29561612] [10.1021/acs.jmedchem.7b01575] |
Source(1):